2012
DOI: 10.1016/j.ygyno.2012.07.001
|View full text |Cite
|
Sign up to set email alerts
|

Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

11
66
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 73 publications
(78 citation statements)
references
References 32 publications
11
66
1
Order By: Relevance
“…In a cohort of 961 Danish women with ovarian cancer, 63% of patients aged less than 70 years were diagnosed in stage III-IV compared with 73% of those aged 70 years or more. Furthermore, whereas 97% in the younger group underwent primary debulking surgery or interval debulking surgery after neoadjuvant chemotherapy, this was only the case for 85% of patients aged 70 years or more and the proportion of optimally debulked patients (residual tumor 51 cm) was 66% versus 51% respectively [17]. Also the number of patients receiving combination chemotherapy (carboplatin plus paclitaxel) was lower in the group of older cancer patients (77% versus 43%).…”
Section: Discussionmentioning
confidence: 93%
“…In a cohort of 961 Danish women with ovarian cancer, 63% of patients aged less than 70 years were diagnosed in stage III-IV compared with 73% of those aged 70 years or more. Furthermore, whereas 97% in the younger group underwent primary debulking surgery or interval debulking surgery after neoadjuvant chemotherapy, this was only the case for 85% of patients aged 70 years or more and the proportion of optimally debulked patients (residual tumor 51 cm) was 66% versus 51% respectively [17]. Also the number of patients receiving combination chemotherapy (carboplatin plus paclitaxel) was lower in the group of older cancer patients (77% versus 43%).…”
Section: Discussionmentioning
confidence: 93%
“…Elderly patients have been less likely to undergo standard treatments for ovarian cancer, such as optimal debulking surgery, and have been less likely to complete chemotherapy. Indeed, it has been reported that, among patients who do receive optimal treatment, old age is not an independent poor prognostic factor [42]. …”
Section: Discussionmentioning
confidence: 99%
“…Age has been shown to influence treatment decisions and outcome in ovarian cancer. 13Y17 However, when older patients receive standard combination chemotherapy, their outcomes are comparable with younger patients, 12 and in our study, age was not an independent prognostic factor. After adjusting for covariates known to affect chemotherapy selection, there was still greater than 5 times higher mortality rate among patients receiving single-agent carboplatin compared with patients receiving combination chemotherapy.…”
Section: Discussionmentioning
confidence: 44%